Key facts
- MycoWorks’s last known valuation is $420.0M.
- It has raised $351.8M across 4 recorded rounds; the latest was Early Stage VC ($37.1M) in Oct 2022.
- Notable investors include SOSV, Gaingels, 8VC, Valor Equity Partners, IndieBio — 29 tracked in total.
- MycoWorks has filed 4 Form Ds with the SEC since 2021, most recently Jun 2023 ($37.1M sold to 11 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 29 names
- ·Watchlist + deal alerts for MycoWorks
Funding rounds
4 roundsAbout MycoWorks
Manufacturer of mycelium products intended to offer natural alternatives to plastic foams, textiles, and leather. The company's products are made from bio-materials using fungal mycelium to create lower energy and biodegradable alternatives to plastic foams, synthetic textiles, engineered woods, and leather for use in aerospace, automobiles, apparel, and architectural interiors, enabling clients to easily get new kinds of leather grown from mycelium and agricultural byproducts in a carbon-negative process.
- Sector
- Materials and Resources
- HQ
- Emeryville, CA, United States
- Founded
- 2014
- Employees
- 250
- Website
- mycoworks.com/
- Ownership
- Privately Held (backing)
MycoWorks doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MycoWorks shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MycoWorks in its N-PORT filings yet. We sweep new filings monthly.